ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ENOB – QNT Press Release

NEW YORK, Sept. 6, 2022 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ:ENOB) between January 17, 2018 and June 27, 2022both dates inclusive, (the “Class Period”), including common stock issued by Enochian in a private placement offering on or about February 16, 2018of the important September 26, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Enochian BioSciences securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Enochian BioSciences class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email or for…

Full story available on

Source link

Recommended For You

About the Author: News Center